NASDAQ: VBIV - VBI Vaccines Inc.

六个月盈利: 0%
股息率: 0.00%
部门: Healthcare

促销时间表 VBI Vaccines Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 VBI Vaccines Inc.

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, an immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus.

更多详情
In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; GlaxoSmithKline Biologicals S.A.; and the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. It also has a collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 1995-08-18
ISIN CA91822J1030
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 0.25
Сайт https://www.vbivaccines.com
Цена ао 0.0282
每日价格变化: 0% (0.0282)
每周价格变化: 0% (0.0282)
每月价格变化: 0% (0.0282)
3个月内价格变化: 0% (0.0282)
六个月内的价格变化: 0% (0.0282)
每年价格变化: -95.01% (0.565)
3年内价格变化: -97.99% (1.4)
5年内价格变化: -98.07% (1.46)
10年价格变化: 0% (0.0282)
年初以来价格变化: 0% (0.0282)
所有参数

低估

姓名 意义 年级
P/S 0.9865 9
P/BV 1.14 9
P/E 0 0
EV/EBITDA -0.7112 0
全部的: 6

效率

姓名 意义 年级
ROA, % -106.77 0
ROE, % -1233.37 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0.7 7
全部的: 1.16

责任

姓名 意义 年级
Debt/EBITDA -0.9947 10
全部的: 8.2

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 294.64 10
盈利能力 Ebitda, % 15.66 3
盈利能力 EPS, % -60.52 0
全部的: 4.6
更多详情

机构 体积 分享, %
Perceptive Advisors LLC 1381355 5.83
Alyeska Investment Group, L.P. 696736 2.94
Geode Capital Management, LLC 138729 0.59
Blackrock Inc. 111960 0.47
Cambridge Investment Research Advisors Inc. 93556 0.39
Millennium Management LLC 71422 0.3
Vanguard Group Inc 64522 0.27
General American Investors Company Inc 62583 0.26
Morgan Stanley 34973 0.15
Northern Trust Corporation 32992 0.14



导师 职称 支付 出生年份
Mr. Jeffery R. Baxter FCMA President, CEO & Director 908.06k 1961 (64 年)
Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. Chief Medical Officer 544.52k 1955 (70 年)
Ms. Nell Beattie CFO, Head of Corporate Development & Director N/A 1988 (37 年)
Ms. Athena Kartsaklis Senior VP of Finance, Chief Compliance Officer & Principal Financial Officer N/A 1965 (60 年)
Mr. Avi Mazaltov Global Head of Manufacturing & GM of SciVac N/A 1962 (63 年)
Mr. Misha Nossov Senior VP of Global Commercial Supply Strategy & Head of Europe N/A
Mr. John Robert Dillman Chief Commercial Officer N/A 1968 (57 年)
Dr. David Evander Anderson Ph.D. Chief Scientific Officer 1970 (55 年)
Ms. Nicole Anderson Director of Corporate Communications & Investor Relations
Mr. T. Adam Buckley B.Sc., MBA Senior Vice President of Business Development 1976 (49 年)

地址: United States, Cambridge. MA, 160 Second Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.vbivaccines.com